Tag: viruses

Scientists Warn Of Urgent AI Biosecurity Threat

For the first time, artificial intelligence has designed complete, functional viral genomes from scratch.

Oh dear.

Stanford University and Arc Institute researchers used generative AI models to produce 16 novel bacteriophages that successfully infect and kill bacteria in the lab.

Officials insist the viruses “pose no threat to people,” yet biosecurity experts are already sounding the alarm that the same technology opens the door to inventing dangerous pathogens.

The breakthrough, published in the journal Science, marks the first time generative AI has written entire viable viral genomes.

Researchers trained genome language models known as Evo 1 and Evo 2 on millions of natural genetic sequences. They then tasked the systems with designing complete bacteriophage genomes based on the well-studied ?X174 template that infects E. coli.

Of 302 synthesized designs, 16 proved fully functional: they assembled into virus particles, replicated inside bacterial cells, and in some cases outperformed the natural virus, even overcoming bacterial resistance when used as a cocktail.

Oh dear.

Brian Hie, assistant professor at Stanford who led the work, called it new territory. “This is a next step in the complexity that’s designable by generative AI, this is the first time generative AI has been used to design a complete genome, it’s something that can replicate and have other functions inside cells… this was new territory for us,” he told the BBC.

The team deliberately excluded genetic data from viruses capable of infecting complex organisms and conducted the work in a secure laboratory. The resulting phages target only specific bacteria.

Patrick Cai, a synthetic biologist at the University of Manchester not involved in the study, called it “an important milestone.”

Yet the same experts who celebrate the medical potential for phage therapies against antibiotic-resistant infections are issuing blunt warnings.

In an accompanying commentary in Science, Dr. Thomas Inglesby and Dr. Moritz Hanke of the Johns Hopkins Center for Health Security wrote that the findings raise “urgent biosafety and biosecurity questions.”

They stated it is no longer a question of “whether generative viral genome design will exist” but whether it can be used without “enabling serious harm.”

Oh dear.

Keep reading

The great FLU ILLUSION: Bombshell study proves transmission is a myth and PCR tests are junk science

Virology misunderstood

If the flu virus is as contagious as we have been told, transmission should have been rampant. It was not. Only one recipient out of 75 became infected. That is a 1.3% secondary attack rate. The researchers expected at least 16%. They missed their target by more than tenfold.

To shed further doubt on virus transmission and the common measures used to protect against viral shedding, the study divided recipients into two groups. The intervention group wore face shields and sanitized their hands every 15 minutes. The control group did neither. The result? Zero infections in the intervention group and one infection in the control group. Statistically, there was no difference between the groups. This finding renders the entire mask debate moot. If face shields and constant hand sanitizer cannot stop transmission when both groups fail to get infected anyway, what exactly are we protecting ourselves from?

Virus transmission appears to be an imaginary concept, driven by fear and hysteria.

The uncomfortable truth about viral shedding

Now, forty-two of the 52 donors who were deliberately infected actually became infected after inoculation. That is an 81% infection rate through direct inoculation. And they shed virus from their noses in substantial quantities. Their viral loads were high enough to register on PCR tests with cycle threshold values in the mid-20s. Yet, remarkably, they did not pass the virus to the people sitting next to them. The researchers also measured the exhaled breath of donors using a device called the Gesundheit-II. They found that only 11 out of 42 infected donors had detectable virus in their breath aerosols. Even then, the quantities were two to four logs lower than what has been observed in naturally infected people who were selected for having fever and high viral loads.

This raises an obvious question. If the virus is so hard to transmit in a controlled setting where infected people are breathing directly onto susceptible people for days, how does it ever spread in the real world? The researchers tried to explain their failure by pointing to the building ventilation system. The proof-of-concept study was conducted in a hotel room with recirculating air, and it did have a higher transmission rate. The follow-on study used mechanical ventilation that diluted the air. They concluded that aerosols might be important after all. But this explanation is circular. If transmission depends on airtight rooms with no fresh air, then the virus is not a robust airborne pathogen. It is a fragile entity that requires extreme conditions to move from one person to another.

The fallacy of the contagious patient

The study also revealed something that should make every public health official reconsider their assumptions. Many of the directly infected donors did not get sick. Ten out of 42 infected donors were classified as asymptomatic. They had the virus in their bodies; it was confirmed through PCR; they shed it from their noses, but they felt fine. No fever, no cough, no runny nose. Yet they were placed in rooms with susceptible people and still did not transmit. The researchers admitted that their model produced donors who were “minimally contagious.” But if a person with a laboratory-confirmed infection who is breathing on you for 15 hours a day cannot make you sick, what does that say about the millions of asymptomatic cases that were used to justify lockdowns, school closures, and mask mandates?

The collective pandemic protection measures were not based on science; they were only used to control people, weaponizing their virtue and their fear.

Keep reading

Neanderthal ancestry may lower defenses against common DNA viruses in people today

Researchers have found surprising links that show that Neanderthal ancestry influences our immune system today in ways more nuanced than previously recognized. Their work is published in the journal Genome Biology and Evolution.

Viruses account for an estimated 10–20% of the global disease burden. Many DNA viruses can persist in the body for a lifetime, and virus load varies greatly even among people without symptoms. Throughout human history, they have posed persistent and rapidly evolving threats, placing strong adaptive pressure on our immune system.

Previous research has shown that many genetic variants involved in immunity bear the marks of these evolutionary battles—including signatures of natural selection and contributions from interbreeding with archaic humans.

While Neanderthal ancestry has previously been associated with beneficial effects in RNA virus defense, the new study highlights a contrasting trend for DNA viruses.

Because of past admixture with archaic humans, around 2% of the genome of present-day non-Africans is composed of Neanderthal DNA and an additional 2–4% of people in Oceania of Denisovan ancestry. These introgressed sequences have shaped many biological traits, including immunity. But their role in defenses against DNA viruses has remained largely unexplored.

Keep reading

2006 Ralph Baric Paper Describes Synthetic ‘Scapegoat’ Viruses Engineered Digitally With False Origin ‘Fingerprints’ to Mislead Investigators

A 2006 paper authored by Dr. Ralph Baric—the University of North Carolina virologist widely recognized as the leading architect of chimeric coronavirus genomes and in silico viral assembly techniques—openly describes how synthetic viral genomics could be used to create viruses digitally, containing misleading genetic “fingerprints” designed to redirect investigators toward a false geographic or evolutionary origin.

The SARS-CoV-2 pathogen of the COVID-19 pandemic would be found to possess exactly the three signature spike features that Baric and his collaborators had explicitly proposed engineering into chimeric SARS-related coronaviruses in the 2018 DARPA/EcoHealth DEFUSE proposal: a furin cleavage site (PRRA) insertion at the S1/S2 junction, targeted human-optimizing mutations throughout the receptor-binding domain (including the critical Q498 residue), and the two-proline (V1060P/L1061P) substitution to stabilize the spike protein in its prefusion conformation.

Also in 2018, Baric was granted U.S. Patent 9,884,895 B2 for “Methods and compositions for chimeric coronavirus spike proteins,” which claims proprietary techniques for modular domain swapping and seamless synthetic computer assembly of coronavirus spikes.

Twelve years earlier, in the very same 2006 paper that first laid out the theoretical framework for such engineered viruses, Baric had already described how computer-designed genomes could be deliberately designed to serve as “scapegoats,” carrying misleading sequence signatures that would misdirect any investigation into their true origin.

The 2006 paper, titled Synthetic Viral Genomics: Risks and Benefits for Science and Society, was published as part of a broader biodefense and synthetic biology review examining the future risks posed by synthetic genomics, reverse genetics, and recombinant viral engineering.

Keep reading

DARPA’s Secret 60-Day Pandemic Pipeline: FOIA Documents Reveal U.S. Military Program to Synthesize Viruses From Digital Sequences and Mass-Produce mRNA Countermeasures

This report examines an October 2025 FOIA release from U.S. Right to Know regarding DARPA’s “Pandemic Prevention Platform (P3)” Research Description Document (RDD) from Duke University, Revision 3 (January 2020)—a program that was already operational before the COVID-19 pandemic began.

DARPA’s own words paint the clearest picture yet of a fully integrated pre-COVID pandemic U.S. military system that can:

  • take only a digital sequence of a virus
  • synthesize an infectious clone
  • grow it in a “Thaw-and-Infect” panel of human and animal cell lines
  • isolate antibodies from infected blood
  • evolve those antibodies using computational mutation engines
  • encode those antibodies into modified mRNA
  • package them in lipid nanoparticles
  • and produce 20,000 doses within 60 days

The program is open about building a platform that works even when no physical virus exists, only a computer file.

Keep reading

CIA allegedly contracted venereal disease among agents

Reports have emerged indicating that the CIA allegedly contracted a strain of venereal disease among its agents. The situation reportedly arose as agents engaged in sexual activity among themselves.

This development raises questions about health protocols within the agency. The nature of the contracted disease and the circumstances surrounding its transmission have not been disclosed.

As previously reported, health-related issues can have significant implications for operational effectiveness. In a similar situation, a recent study found that COVID-19 during pregnancy increases autism risk in children, highlighting the importance of health management in various contexts. For more information, see recent developments in health.

The CIA has not yet issued a public statement regarding these allegations.

Keep reading

The Curious Case of Norovirus

First discovered in 1972, Norovirus is a highly contagious positive-stranded RNA virus that causes acute gastroenteritis (often called the “stomach flu”), which leads to significant global mortality, primarily through dehydration and complications in vulnerable populations such as young children and older adults. According to the most recent (modeling-based) estimates from the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), the annual global mortality attributable to norovirus infection is approximately 200,000 deaths. This figure includes about 50,000 deaths among children under 5 years old, with the majority occurring in low- and middle-income countries where access to healthcare and sanitation is limited.

Norovirus causes around 685 million illnesses worldwide each year, but only a small fraction result in death due to its generally self-limiting nature. However, in high-risk groups, severe dehydration can be fatal without prompt intervention. Over 99% of deaths occur in developing regions, particularly Southeast Asia and Africa, which account for about 85% of norovirus-related fatalities. About 50,000 deaths occur annually in children under 5 years of age, often linked to malnutrition and poor hygiene. In those over 65 years of age, there is a higher risk of death in both developed and developing countries, estimated at about 800 deaths per year in the USA.

By comparison, as of March 7, 2023, the CDC reports 38 deaths classified as mpox-associated among persons with probable or confirmed monkeypox (DNA virus) in the United States during the period from May 10, 2022, to March 7, 2023. The recent monkeypox outbreak was treated as a major national and international health crisis, and a vaccine designed for preventing smallpox was deployed to provide immunity against the related monkeypox virus. This was done on an emergency use basis, with little or no clinical data to support that decision. For purposes additional comparison, adults aged 65 and older, an estimated 6,000 to 10,000 deaths occur each year due to RSV (respiratory RNA virus) in the USA.

Like Polio, morbidity and mortality (sickness and death) is largely preventable through hand hygiene, safe food handling, and clean water. In developed countries, norovirus has become the leading cause of foodborne illness outbreaks, while in developing regions, it exacerbates broader diarrheal disease burdens.

Shellfish and salad ingredients are the foods most often implicated in norovirus outbreaks. Ingestion of shellfish that have not been sufficiently heated – under 75 °C (167 °F) – poses a high risk for norovirus infection. Foods other than shellfish may be contaminated by infected food handlers. Many norovirus outbreaks have been traced to food that only one infected person handled.

Keep reading

Next Plandemic? Drug-Resistant BAT-HUMAN HYBRID FLU Engineered by NIH-funded Researchers

The depopulation machine is still in full gear, folks. The freaks in their white lab coats are still designing new plandemics with new deadly diseases and clot shots to go with it. Here’s the latest scoop.

A new peer-reviewed study published June 18, 2025, in Pathogens has revealed that scientists funded by the U.S. National Institutes of Health (NIH) have genetically engineered novel hybrid influenza viruses combining bat and human virus components. The research, conducted at the University of Missouri and partially funded by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), raises significant public health and biosecurity concerns.

    • NIH-Funded Creation of Hybrid Bat-Human Influenza Viruses: Researchers at the University of Missouri, funded by NIH and CEIRR grants, engineered chimeric influenza viruses by combining bat virus genes with human H1N1 components—raising significant concerns due to their ability to replicate in mammalian cells and resist common antivirals.
    • Engineered for Antiviral Resistance and Survival: The viruses were deliberately mutated at key sites (e.g., N31, H37, W41) to confer resistance to amantadine, a standard flu treatment, and to study how these mutations affect viral replication and survival, confirming the study’s gain-of-function nature.
    • Pandemic Potential and Biosecurity Fears: Constructed using reverse genetics, these lab-created viruses could potentially infect humans, making them highly controversial in light of past pandemic origins linked to lab-based virus manipulation and prompting renewed biosecurity concerns.
    • S. Taxpayer-Funded and Internationally Overseen: Despite growing public and governmental scrutiny, this research received funding from U.S. agencies including NIH/NIAID and CEIRR, with involvement from WHO-affiliated scientists and formal biosafety clearance—further fueling debate over accountability and transparency in high-risk virology.

Keep reading

Report: USAID Quietly Sent Thousands of Viruses to the Infamous Wuhan Lab

The U.S. Agency for International Development (USAID) reportedly shipped thousands of viruses to a Chinese military-linked biolab in Wuhan.

USAID sent 11,000 viral samples to the Wuhan Institute of Virology (WIV) over the course of a ten-year program, despite not having any formal agreement with the laboratory, according to documents obtained by Daily Caller.

The viruses were reportedly sent from China’s Yunnan province to Wuhan — the infamous epicenter of the Chinese coronavirus pandemic — with the exportation being funded by the USAID, which seemingly failed to devise a strategy that would prevent the samples from becoming bioweapons and staying accessible to the U.S. government.

Notably, the Wuhan Institute of Virology lacks adequate biosafety practices and has ties to the Chinese Communist Party (CCP)’s military, People’s Liberation Army (PLA).

The $210 million USAID program, dubbed PREDICT — which failed to implement a long-term storage plan when funding ceased — was spearheaded by the University of California-Davis and involved gathering virus samples from countries around the world.

Among the thousands of viral samples sent via USAID funding to the Wuhan lab is one of the closest known relatives of the Chinese coronavirus that ravaged the world in 2020, Daily Caller noted.

“Investigations involving USAID’s former funding of global health awards remain active and ongoing,” a senior State Department official told the outlet. “The American people can rest assured knowing that under the Trump Administration we will not be funding these controversial programs.”

Last week, USAID was finally shuttered after President Donald Trump’s Department of Government Efficiency (DOGE) uncovered a slew of examples of waste, fraud, and abuse of taxpayer dollars.

“Beyond creating a globe-spanning NGO industrial complex at taxpayer expense, USAID has little to show since the end of the Cold War,” U.S. Secretary of State Marco Rubio said.

Keep reading

Microbiologist, Residents Say China Conceals Extent Of Respiratory Virus Outbreak

Chinese health authorities have said this winter’s flu season is less severe than the year before, but medical experts cast doubts over the transparency of its respiratory illness situation.

Residents from four different cities have expressed concerns about an uptick in respiratory infections within their families and communities when speaking to The Epoch Times.

Some suspected their flu-like symptoms may actually be caused by COVID-19, fearing that doctors were instructed to avoid such diagnoses, given that the authorities declared a victory in its fight against the pandemic almost two years ago.

In Shenyang, northern China, a woman named Xu said she’s noticed more people sick with respiratory illnesses have seen local hospitals packed again during the Lunar New Year holiday.

“I’m feeling unwell myself and haven’t recovered. The hospital said I contracted influenza A, but I believe it’s just COVID-19,” Xu told The Epoch Times on Feb. 7. She expressed concerns about how quickly the virus circulated among humans this time, saying her son, daughter-in-law, and their school-aged daughter have all fallen ill. “The authorities are concealing the scale of the outbreak.”

Flu Toll Questioned

China’s top health body has acknowledged the country is grappling with a spike in respiratory infectious illness, but said the rate of influenza has shown signs of slowing down.

During the regime’s most recent briefing, National Health Commission (NHC) officials reiterated its previous assessment, saying the scale and intensity of the spread of respiratory infectious diseases this year is lower than it was during the previous winter season.

“No new infectious disease had been detected,” Mi Feng, NHC’s spokesperson, told reporters on Jan. 17, ahead of the week-long Lunar New Year holiday, attributing the current infections to a combination of known germs, most prominently influenza. No data was provided during the briefing.

It remains unclear how many people were infected with the influenza virus or COVID-19 this year. The latest figures showed 112 COVID-19 infections and seven deaths in December 2024, according to a monthly report from China’s Center for Disease Control and Prevention. Since December 2022, after a leaked recording of an internal NHC meeting indicated the COVID outbreaks were far worse than the official tallies indicated, the top health regulator stopped publishing daily COVID figures and transitioned COVID-related updates to its sub-department, CDC.

In a separate report, the CDC reported 1.5 million influenza cases last December, leading to seven deaths.

Medical experts have questioned the accuracy of these flu statistics.

“It’s clear that the mortality rate is being underreported,” Sean Lin, a virologist and former lab director at the viral disease branch of the U.S. Walter Reed Army Institute of Research, told The Epoch Times.

Keep reading